277295-93-9

Usage

Uses

Used in Pharmaceutical Synthesis:
(R)-2-Amino-2-(3,4-difluorophenyl)ethanol is used as an intermediate in the synthesis of pharmaceutical compounds and other organic molecules. Its unique structure and chirality make it a crucial component in the development of new drugs and therapeutic agents.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (R)-2-Amino-2-(3,4-difluorophenyl)ethanol is used as a building block for creating new drug candidates. Its specific stereochemistry allows for the design and synthesis of novel compounds with potential therapeutic applications.
Used in Antimicrobial Applications:
(R)-2-Amino-2-(3,4-difluorophenyl)ethanol is studied for its potential antimicrobial properties, which could be utilized in the development of new antibiotics or antifungal agents to combat resistant strains of bacteria and fungi.
Used in Antiviral Applications:
(R)-2-AMino-2-(3,4-difluorophenyl)ethanol is also explored for its possible antiviral properties, which may contribute to the development of new antiviral drugs to treat various viral infections.
Used in Chemical and Pharmaceutical Industries:
(R)-2-Amino-2-(3,4-difluorophenyl)ethanol is used as a key intermediate in the chemical and pharmaceutical industries for the synthesis of various compounds with diverse applications, including those in the medical and healthcare sectors.

Upstream product

• 218449-30-0 amino-(3,4-difluorophenyl)-acetonitrile 
• 34036-07-2 3,4 difluorobenzaldehyde 
• 225641-91-8 4-(3,4-difluorophenyl)-2-oxazolidinone 
• 60-29-7 diethyl ether 
• 218449-31-1 amino-(3,4-difluorophenyl)-acetic acid methyl ester 

Downstream Products

• 218451-28-6 (+)-3-(3-(4-cyano-4-(2,4-dichloro)phenylpiperidin-1-yl)propyl)aminocarbonyl-4-(3,4-difluorophenyl)-2-oxazolidinone 
• 218451-40-2 (+)-3-(3-(4-Aminocarbonyl-4-(4-chloro)phenylpiperidin-1-yl)-propyl)aminocarbonyl-4-(3,4-difluoro)phenyl-2-oxazolidinone 
• 218449-37-7 4-(3,4-difluorophenyl)-2-oxo-oxazolidine-3-carboxylic acid-4-nitro-phenyl ester 
• 225641-91-8 4-(3,4-difluorophenyl)-2-oxazolidinone 
• 1609164-81-9 rac-8-[(2,6-difluorobenzyl)oxy]-N-[1-(3,4-difluorophenyl)-2-hydroxyethyl]-2-methylimidazo[1,2-a]pyridine-3-carboxamide 
• 218449-35-5 [1-(3,4-difluorophenyl)-2-hydroxy-ethyl]-carbamic acid-tert-butyl ester 

Relevant academic research and scientific papers

BENZOPYRAZOLE COMPOUND USED AS RHO KINASE INHIBITOR

The invention relates to a benzopyrazole compound used as RHO kinase inhibitor, a pharmaceutical composition and uses thereof for preparing an RHO kinase inhibiting drug, and more specifically to said compound of formula (I-1), a pharmaceutically acceptable salt and isomer thereof.

SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS

This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therepeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.

MORPHOLINONE AND MORPHOLINE DERIVATIVES AND USES THEREOF

This invention is directed to morpholinone and morpholine derivatives which are selective antagonists for human α 1a receptors. This invention is also related to uses of these compounds for lowering intraocular pressure, inhibiting cholesterol synthesis, relaxing lower urinary tract tissue, the treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia, sympathetic mediated pain, migraine, and for the treatment of any disease where the antagonism of the α 1a receptor may be useful. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.

Oxazolidinones as alpha 1A receptor antagonists

This invention is directed to oxazolidinone compounds which are selective antagonists for human alpha 1A receptors. This invention is also related to uses of these compounds for lowering intraocular pressure, inhibiting cholesterol synthesis, relaxing lower urinary tract tissue, the treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia and for the treatment of any disease where the antagonism of the alpha 1A receptor may be useful. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.